Tyra Biosciences, Inc.
TYRA
$20.92
$0.110.53%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.87M | -28.10M | -28.15M | -25.57M | -24.02M |
| Total Depreciation and Amortization | 131.00K | 140.00K | 143.00K | 144.00K | 127.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.16M | 5.67M | 5.56M | 5.52M | 5.97M |
| Change in Net Operating Assets | 199.00K | -1.39M | -3.01M | 318.00K | 23.00K |
| Cash from Operations | -22.38M | -23.68M | -25.46M | -19.59M | -17.90M |
| Capital Expenditure | -39.00K | -31.00K | -14.00K | -6.00K | -52.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.77M | 20.90M | 32.04M | 6.96M | 21.61M |
| Cash from Investing | -14.81M | 20.87M | 32.03M | 6.96M | 21.56M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 647.00K | 583.00K | 2.19M | 706.00K | 743.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 647.00K | 583.00K | 2.19M | 706.00K | 743.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.54M | -2.23M | 8.76M | -11.93M | 4.40M |